Hear from ZS experts, Lisa Bance, PharmD, MBA, Irina Groysman, PharmD, and Laurent Malivert, PhD, on the impact Virtual Reality technologies are having in the healthcare space. Explore opportunities for how VR can be leveraged in shaping clinical trials and in how clinical development and operations leaders can not only navigate through disruption but thrive in an era of reduced physical access. Live: Thursday, October 8, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Oct. 8, 2021.
Register free: https://www.pharmexec.com/pe_w/virtual_reality
Event Overview:
Barriers in trial recruitment and retention significantly add to the cost of a trial and can result in trial delays that impact getting a needed drug to the market in a timely manner. Trial simulations are a powerful way of gathering patient feedback that can be used to ensure a trial is designed in a manner that supports a patients’ interest in being in a trial and completing the trial. However, physical trial simulations have many limitations. Join ZS experts to learn how Virtual Reality can improve trial experiences for patients and investigators involved in the design and marketing phases and ongoing running and operations. Explore how VR can educate patients, incorporate their voices and perspectives in trial designs, improve trial recruitment and overall experience, and support better engagement between patients and sites.
Key Learning Objectives:
Speakers: Lisa Bance, PharmD, MBA, Associate Principal, ZS Associates
Irina Groysman, PharmD, Consultant, ZS Associates
Laurent Malivert, PHD, Consultant, ZS Associates
Time and date: Thursday, October 8, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
On demand available after airing until Oct. 8, 2021.
Sponsor: ZS Associates
Register free: https://www.pharmexec.com/pe_w/virtual_reality